Dallas Health Plan Faces $17M Deficit Due to GLP-1 Drug Costs
Dallas’ employee health plan is facing a $17 million budget shortfall, primarily driven by a surge in claims for GLP-1 receptor agonist medications used for weight management. This financial strain ... Read More